Blake Ingle Insider Profile
4 Followers
Blake Ingle, former Director at Dendreon Corp, holds 12.50K shares in Dendreon Corp (Ticker: DNDNQ), holds 0.00 shares in Fresh Tracks Therapeutics (Ticker: FRTX). Most recently, Blake Ingle Bought ― shares of Dendreon Corp on Apr 30, 2009 for an estimated value of $503.12K.
Blake Ingle's Trading History
| DNDNQDendreon Corp | Apr 30, 2009 | ― | Informative Buy | 503.12K | ― | |
| FRTXFresh Tracks Therapeutics | ― | ― | ― | $0.00 |
You May Also Like
Blake Ingle insider profile FAQ
What is the percentage of profitable transactions made by Blake Ingle?
The percentage of profitable transactions made by Blake Ingle is 0%.
What is the average return per transaction made by Blake Ingle?
The average return per transaction made by Blake Ingle is -77.50%.
What stocks does Blake Ingle hold?
Blake Ingle holds: DNDNQ, FRTX stocks.
What was Blake Ingle’s latest transaction?
Blake Ingle’s latest transaction was an Informative Buy of $503.12K.
What was Blake Ingle's most profitable transaction?
Blake Ingle’s most profitable transaction was an Informative Buy of DNDNQ stock on April 30, 2009. The return on the trade was 0.00%.
What is Blake Ingle's role in Dendreon Corp?
Blake Ingle's role in Dendreon Corp is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
